• Thu. Apr 23rd, 2026

McKesson, Merck back Atropos Health’s $30M round to accelerate drug development with AI

By

May 23, 2024

Atropos Health raises $30 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development.Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Generated by Feedzy